| Objectives: Cisplatin is one of the common chemotherapy drugs for bladder cancer, and resistance to this drug is one of the major
obstacles to effective chemotherapy. MicroRNAs (miRNAs) are a category of small noncoding RNAs that can regulate the expression of
numerous genes. Recent studies showed that miRNAs can act as a powerful regulator of chemo-sensitivity in cancer cells. Hence, this study
aimed to investigate the effects of miRNA-486-5p on cisplatin-sensitivity of different bladder cancer cells.
Material and Methods: The 5637 and EJ138 cancer cells were treated with miRNA-486-5p and cisplatin, individually or in
combination.
Results: Afterward, the cytotoxicity effects of these treatments were determined by MTT assay and the increased cisplatin-sensitivity
observed in both cell lines, especially, 5637 cells. Moreover, subG1 phase cell cycle arrest, changes in the expression of caspase-9, caspase-
3, P53, SIRT1, OLFM4, SMAD2, and Bcl-2 genes and nuclear fragmentation also revealed the induction of apoptosis in all treatments,
which increased in combination groups. Also, the combination of miRNA-486-5p with cisplatin significantly down-regulated the expression
of migration associated genes including ROCK, CD44, and MMP-9 as compared with cisplatin alone.
Conclusion: Altogether, these results indicated that the miRNA-486-5p could induce apoptosis and inhibit cell migration ability of the
cells. It seems that pre-electroporation of cells with miRNA-486-5p has useful results in the enhancement of cisplatin sensitivity of 5637
and EJ138 cancer cells and this combination may be a promising treatment strategy for bladder cancer therapy. 2020 Elsevier Inc. All
rights reserved. |